Filtros de búsqueda

Lista de obras de Jeffrey Cummings

3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects

artículo científico publicado en 2010

3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease

artículo científico publicado en 2006

3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI.

artículo científico publicado en 2010

3D mapping of language networks in clinical and pre-clinical Alzheimer's disease

artículo científico publicado en 2007

3D mapping of mini-mental state examination performance in clinical and preclinical Alzheimer disease

artículo científico publicado en 2006

A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease

artículo científico publicado en 2003

A counseling intervention for caregivers: effect on neuropsychiatric symptoms

artículo científico publicado en 2004

A modern hypothesis: The distinct pathologies of dementia associated with Parkinson's disease versus Alzheimer's disease

artículo científico publicado en 2008

A new measurement of activities of daily living for Thai elderly with dementia.

artículo científico publicado en 2003

A potential role of the curry spice curcumin in Alzheimer's disease

artículo científico publicado en 2005

A practical algorithm for managing Alzheimer's disease: what, when, and why?

artículo científico publicado en 2015

A review: treatment of Alzheimer's disease discovered in repurposed agents

artículo científico

A rivastigmine patch for the treatment of Alzheimer's disease and Parkinson's disease dementia

artículo científico publicado en 2007

A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.

artículo científico publicado en 2009

A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium

artículo científico publicado en 2008

A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patchversus capsule

article by Bengt Winblad et al published 2007 in International Journal of Geriatric Psychiatry

ABBY: A phase 2 randomized trial of crenezumab in mild to moderate Alzheimer disease.

artículo científico publicado en 2018

ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials

artículo científico publicado en 2016

ADCS Prevention Instrument Project: behavioral measures in primary prevention trials.

artículo científico publicado en 2006

ADCS Prevention Instrument Project: development of a brief verbal memory test for primary prevention clinical trials

artículo científico publicado en 2006

ADCS Prevention Instrument Project: overview and initial results

artículo científico publicado en 2006

Adaptive crossover designs for assessment of symptomatic treatments targeting behaviour in neurodegenerative disease: a phase 2 clinical trial of intranasal oxytocin for frontotemporal dementia (FOXY)

scholarly article by Elizabeth Finger et al published 27 September 2018 in Alzheimers Research & Therapy

Added Clinical Benefit of Incorporating 2-Deoxy-2-[F]Fluoro-D-Glucose with Positron Emission Tomography into the Clinical Evaluation of Patients with Cognitive Impairment ⬇️

artículo científico publicado el 1 de julio de 2002

Advances in designs for Alzheimer's disease clinical trials.

artículo científico publicado en 2012

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

artículo científico publicado en 2014

Age and rate of cognitive decline in Alzheimer disease: implications for clinical trials

artículo científico publicado en 2012

Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition

artículo científico publicado en 2014

Agitation in dementia: relation to core cerebrospinal fluid biomarker levels

artículo científico publicado en 2014

Alterations in NMDA receptor subunit densities and ligand binding to glycine recognition sites are associated with chronic anxiety in Alzheimer's disease

artículo científico publicado en 2007

Alzheimer disease.

artículo científico publicado en 2002

Alzheimer's disease biomarkers in animal models: closing the translational gap.

artículo científico publicado en 2013

Alzheimer's disease biomarkers: correspondence between human studies and animal models

artículo científico

Alzheimer's disease clinical trials: changing the paradigm.

artículo científico publicado en 2011

Alzheimer's disease clinical trials: where are we now?

artículo científico publicado en 2006

Alzheimer's disease diagnostic criteria: practical applications

artículo científico publicado en 2012

Alzheimer's disease drug development pipeline: 2017.

artículo científico publicado en 2017

Alzheimer's disease drug development pipeline: 2018.

artículo científico publicado en 2018

Alzheimer's disease drug development: translational neuroscience strategies

artículo científico

Alzheimer's disease drug-development pipeline: few candidates, frequent failures

artículo científico publicado en 2014

Alzheimer's disease progression by geographical region in a clinical trial setting

artículo científico publicado en 2015

Alzheimer's disease summit. Translating research advances into clinical practice. Introduction.

artículo científico publicado en 2008

Alzheimer's disease: clinical trials and the amyloid hypothesis.

artículo científico publicado en 2011

Alzheimer's disease: from molecular biology to neuropsychiatry

artículo científico publicado en 2003

Alzheimer's drug-development pipeline: 2016.

artículo científico publicado en 2016

Animal systems in the development of treatments for Alzheimer's disease: challenges, methods, and implications

artículo científico

Apathy and executive function in Alzheimer's disease

artículo científico publicado en 2002

Apathy in Neurodegenerative Diseases: Recommendations on the Design of Clinical Trials

artículo científico

Apathy symptom profile and behavioral associations in frontotemporal dementia vs dementia of Alzheimer type

artículo científico publicado en 2009

Apolipoprotein epsilon4 status is associated with behavioral symptoms in nursing home residents with dementia.

artículo científico publicado en 2009

Association of GSK3B with Alzheimer disease and frontotemporal dementia

artículo científico publicado en 2008

Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer disease

artículo científico publicado en 2004

Automated 3D mapping of baseline and 12-month associations between three verbal memory measures and hippocampal atrophy in 490 ADNI subjects

artículo científico publicado en 2010

Awareness of Psychiatric Symptoms in a Mixed Clinical Sample of Older Adults

scientific article published on 11 August 2019

Behavioral and neuropsychiatric outcomes in Alzheimer's disease.

artículo científico publicado en 2005

Behavioral disorders and caregivers' reaction in Taiwanese patients with Alzheimer's disease.

artículo científico publicado en 2001

Behavioral effects of current Alzheimer's disease treatments: a descriptive review

scientific article published on January 2008

Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment.

artículo científico publicado en 2006

Behavioural changes and psychological symptoms in dementia disorders

artículo científico publicado en 2005

Biomarkers in Alzheimer's disease drug development.

artículo científico publicado en 2011

Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases

artículo científico publicado en 2004

Caregiver-Administered Neuropsychiatric Inventory (CGA-NPI).

artículo científico publicado en 2004

Cerebrospinal fluid biomarkers and proximity to diagnosis in preclinical familial Alzheimer's disease

artículo científico publicado en 2012

Challenges to demonstrating disease-modifying effects in Alzheimer's disease clinical trials.

artículo científico publicado en 2006

Cholinesterase Inhibitor Therapies and Neuropsychiatric Manifestations of Alzheimer’s Disease ⬇️

artículo científico publicado el 15 de octubre de 2003

Cholinesterase Inhibitors in Non-Alzheimer Dementias

artículo científico publicado el 1 de noviembre de 2003

Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease

artículo científico publicado en 2011

Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future.

artículo científico publicado en 2018

Clinical diagnostic criteria for dementia associated with Parkinson's disease

artículo científico publicado en 2007

Clinical evaluation as a biomarker for Alzheimer's disease

artículo científico publicado en 2005

Clinical trials in predementia stages of Alzheimer disease

artículo científico publicado en 2013

Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer's Disease

artículo científico publicado en 2015

Cognitive and functional decline and their relationship in patients with mild Alzheimer's dementia

artículo científico publicado en 2015

Collaborative research between academia and industry using a large clinical trial database: a case study in Alzheimer's disease

artículo científico publicado en 2011

Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Establishing a national biomarker database: utility and incentives.

artículo científico publicado en 2009

Commentary on: L-methylfolate, methylcobolamine, and N-acetylcysteine in the treatment of Alzheimer's disease-related cognitive decline.

artículo científico publicado en 2010

Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions

artículo científico publicado en 2010

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

artículo científico publicado en 2011

Comorbidity in dementia: an autopsy study

artículo científico publicado en 2004

Comparing recruitment, retention, and safety reporting among geographic regions in multinational Alzheimer's disease clinical trials

artículo científico publicado en 2015

Comparison of neuropsychological functioning in Alzheimer's disease and frontotemporal dementia

artículo científico publicado en 1996

Concordance of the Montreal cognitive assessment with standard neuropsychological measures

artículo científico publicado en 2015

Controversies in Alzheimer's disease drug development

artículo científico publicado en 2008

Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps

artículo científico publicado en 2006

Cortical and hippocampal atrophy in patients with autosomal dominant familial Alzheimer's disease

artículo científico publicado en 2011

Creativity and dementia: emerging diagnostic and treatment methods for Alzheimer's disease.

artículo científico publicado en 2008

Current and emerging pharmacological treatment options for dementia

artículo científico publicado en 2006

Current concepts of mild cognitive impairment and their applicability to persons at-risk for familial Alzheimer's disease

artículo científico publicado en 2009

Current state of Alzheimer's fluid biomarkers

scholarly article by José Luis Molinuevo et al published 1 December 2018 in Acta Neuropathologica

Current therapeutic targets for the treatment of Alzheimer's disease

artículo científico publicado en 2010

Deficits in facial emotion processing in mild cognitive impairment

artículo científico publicado en 2007

Defining and labeling disease-modifying treatments for Alzheimer's disease.

artículo científico publicado en 2009

Delusional thoughts and regional frontal/temporal cortex metabolism in Alzheimer's disease

artículo científico publicado en 2003

Dementia with parkinsonism: what is the diagnosis?

artículo científico publicado en 2004

Dextromethorphan-Quinidine for Agitation in Alzheimer Disease--Reply

artículo científico publicado en 2016

Diagnosing depression in Alzheimer disease with the national institute of mental health provisional criteria

artículo científico publicado en 2008

Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations

artículo científico publicado en 2007

Discovering new treatments for Alzheimer's disease by repurposing approved medications

artículo científico publicado en 2013

Disease modification and Neuroprotection in neurodegenerative disorders

artículo científico publicado en 2017

Disease-modifying therapies for Alzheimer disease: challenges to early intervention

artículo científico publicado en 2007

Disease-modifying therapies in Alzheimer's disease

artículo científico publicado en 2008

Disrupted muscarinic M1 receptor signaling correlates with loss of protein kinase C activity and glutamatergic deficit in Alzheimer's disease

artículo científico publicado en 2006

Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer's disease

artículo científico publicado en 2016

Drug development in Alzheimer's disease: the path to 2025

artículo científico publicado en 2016

Dysprosodic speech following basal ganglia insult: toward a conceptual framework for the study of the cerebral representation of prosody

artículo científico publicado en 2006

Early behavioural changes in familial Alzheimer's disease in the Dominantly Inherited Alzheimer Network

artículo científico publicado en 2015

Early-onset Alzheimer's disease is associated with greater pathologic burden

artículo científico publicado en 2007

Effect Size Analyses of Souvenaid in Patients with Alzheimer's Disease

artículo científico publicado en 2016

Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial

artículo científico

Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials

artículo científico publicado en 2018

Effect of donepezil on cognition in severe Alzheimer's disease: a pooled data analysis

artículo científico publicado en 2010

Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease

artículo científico publicado en 2011

Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study

artículo científico publicado en 2007

Effective pharmacologic management of Alzheimer's disease

artículo científico publicado en 2007

Effectiveness of donepezil in reducing clinical worsening in patients with mild-to-moderate alzheimer's disease

artículo científico publicado en 2009

Effects of ApoE4 and maternal history of dementia on hippocampal atrophy

artículo científico publicado en 2010

Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid

artículo científico publicado en 2017

Effects of donepezil 23 mg on Severe Impairment Battery domains in patients with moderate to severe Alzheimer's disease: evaluating the impact of baseline severity

artículo científico publicado en 2013

Effects of donepezil on activities of daily living: integrated analysis of patient data from studies in mild, moderate and severe Alzheimer's disease

artículo científico publicado en 2010

Effects of donepezil on neuropsychiatric symptoms in patients with dementia and severe behavioral disorders

artículo científico publicado en 2006

Effects of oral rivastigmine on cognitive domains in mild-to-moderate Alzheimer's disease

artículo científico publicado en 2010

Effects of rivastigmine in Alzheimer's disease patients with and without hallucinations

artículo científico publicado en 2010

Effects of rivastigmine transdermal patch and capsule on aspects of clinical global impression of change in Alzheimer's disease: a retrospective analysis

artículo científico publicado en 2010

Effects of rivastigmine treatment on the neuropsychiatric and behavioral disturbances of nursing home residents with moderate to severe probable Alzheimer's disease: a 26-week, multicenter, open-label study

artículo científico publicado en 2005

Effects of testosterone on cognition and mood in male patients with mild Alzheimer disease and healthy elderly men.

artículo científico publicado en 2005

Efficacy of higher dose 13.3 mg/24 h rivastigmine patch on instrumental activities of daily living in patients with mild-to-moderate Alzheimer's disease

artículo científico publicado en 2013

Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy

scientific article published on June 2008

Enrichment factors for clinical trials in mild-to-moderate Alzheimer's disease

artículo científico publicado en 2019

Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative

artículo científico publicado en 2012

Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer's disease: analysis of effects of baseline features on treatment response

artículo científico publicado en 2013

Evaluation of dementia rating scales in Parkinson's disease dementia.

artículo científico publicado en 2009

Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study

artículo científico publicado en 2018

Executive dysfunction and apathy predict functional impairment in Alzheimer disease

artículo científico publicado en 2003

Executive dysfunction in Alzheimer disease

artículo científico publicado en 2004

Fluid Biomarkers in Clinical Trials of Alzheimer's Disease Therapeutics

artículo científico publicado en 2015

Food for thought: Souvenaid in mild Alzheimer’s disease

artículo científico publicado en 2012

Frequency and Characteristics of Anxiety Among Patients With Alzheimer's Disease and Related Dementias ⬇️

artículo científico publicado el 1 de enero de 2003

Frontal-subcortical dementias

artículo científico publicado en 2008

Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug development

artículo científico

Frontotemporal dementia classification and neuropsychiatry

artículo científico publicado en 2002

Functional ability in executive variant Alzheimer's disease and typical Alzheimer's disease

artículo científico publicado en 2002

Genetic Risk of Alzheimer's Disease: Three Wishes Now That the Genie is Out of the Bottle

article published in 2018

Genotype, proteotype, phenotype relationships in neurodegenerative diseases. Highlights from the 21st Ipsen Foundation Alzheimer's Disease Symposium, September 13, 2004, Paris, France.

artículo científico publicado en 2005

Globalization of Alzheimer's disease clinical trials

artículo científico publicado en 2011

Guidelines for managing Alzheimer's disease: Part II. Treatment.

artículo científico publicado en 2002

Guidelines for managing Alzheimer's disease: part I. Assessment

artículo científico publicado en 2002

Has the management of Alzheimer's disease changed over the past 100 years?

artículo científico publicado en 2006

Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical "disconnection" in aging and Alzheimer's disease

artículo científico publicado en 2004

High-dose donepezil (23 mg/day) for the treatment of moderate and severe Alzheimer's disease: drug profile and clinical guidelines

artículo científico publicado en 2013

Higher working memory predicts slower functional decline in autopsy-confirmed Alzheimer's disease

artículo científico publicado en 2014

Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia

artículo científico publicado en 2010

Incidence of dementia and subtypes: A cohort study in four regions in China

artículo científico publicado en 2015

Increased fMRI signal with age in familial Alzheimer's disease mutation carriers

artículo científico publicado en 2010

Increased prevalence of significant recurrent headache in preclinical familial Alzheimer's disease mutation carriers.

artículo científico publicado en 2008

Independence of changes in behavior from cognition and function in community-dwelling persons with Alzheimer's disease: a factor analytic approach

artículo científico publicado en 2005

Independent contributions of neural and "higher-order" deficits to symptoms in Alzheimer's disease: a latent variable modeling approach

artículo científico publicado en 2006

Insights into globalization: comparison of patient characteristics and disease progression among geographic regions in a multinational Alzheimer's disease clinical program

scholarly article by Jeffrey L. Cummings et al published 24 November 2018 in Alzheimers Research & Therapy

Integrating ADNI results into Alzheimer's disease drug development programs

artículo científico publicado en 2010

International Work Group criteria for the diagnosis of Alzheimer disease

artículo científico publicado en 2013

Lessons Learned from Alzheimer Disease: Clinical Trials with Negative Outcomes

artículo científico publicado en 2017

Management of agitation and aggression associated with Alzheimer disease

artículo científico publicado en 2009

Management of behavioral problems in Alzheimer's disease

scientific article published on 25 January 2010

Mary S. Easton Center of Alzheimer's Disease Research at UCLA: advancing the therapeutic imperative

artículo científico publicado en 2010

Measuring disease modification in Alzheimer's disease.

artículo científico publicado en 2007

Medical Clinics of North America. Early diagnosis and intervention in predementia Alzheimer's disease. Preface.

artículo científico publicado en 2013

Memory performance and fMRI signal in presymptomatic familial Alzheimer's disease

artículo científico publicado en 2012

Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study

artículo científico publicado en 2005

Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer's disease

scientific article published on 21 December 2012

Mild cognitive impairment (MCI) represents early-stage Alzheimer's disease.

artículo científico publicado en 2005

Mild cognitive impairment is associated with characteristic neuropsychiatric symptoms

artículo científico publicado en 2004

Moderating effects of sex on the impact of diagnosis and amyloid positivity on verbal memory and hippocampal volume

artículo científico publicado en 2017

Network-based assessment of collaborative research in neuroscience

Neurobiology of Alzheimer's Disease: Integrated Molecular, Physiological, Anatomical, Biomarker, and Cognitive Dimensions

artículo científico publicado en 2015

Neuropathologic correlates of activities of daily living in Alzheimer disease

artículo científico publicado en 2006

Neuropathologic correlates of apathy in Alzheimer's disease

artículo científico publicado en 2006

Neuropathologic correlates of trial-related instruments for Alzheimer's disease

scientific article published on 28 March 2014

Neuropsychiatric and behavioral symptoms in a community sample of Hispanics with Alzheimer's disease

artículo científico publicado en 2006

Neuropsychiatric evaluation in dementia

artículo científico publicado en 2008

Neuropsychiatric inventory workshop: behavioral and psychologic symptoms of dementia in Asia.

artículo científico publicado en 2006

Neuropsychiatric manifestations in mild cognitive impairment: a systematic review of the literature

artículo científico publicado en 2007

Neuropsychiatric symptoms and quality of life in Alzheimer disease.

artículo científico publicado en 2005

Neuropsychiatric symptoms are associated with progression from mild cognitive impairment to Alzheimer's disease.

artículo científico publicado en 2007

Neuropsychiatric symptoms, functional impairment and executive ability in Thai patients with Alzheimer's disease.

artículo científico publicado en 2005

Novel late-onset Alzheimer disease loci variants associate with brain gene expression

artículo científico publicado en 2012

Novel tau polymorphisms, tau haplotypes, and splicing in familial and sporadic frontotemporal dementia

artículo científico publicado en 2003

On the path to 2025: understanding the Alzheimer's disease continuum

artículo científico publicado en 2017

Optimizing phase II of drug development for disease-modifying compounds.

artículo científico publicado en 2008

Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study

artículo científico publicado en 2012

PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses

artículo científico publicado en 2010

Performance of a shortened Scale for Assessment of Positive Symptoms for Parkinson's disease psychosis

artículo científico publicado en 2012

Persistence of neuropsychological testing deficits in mild cognitive impairment

artículo científico publicado en 2009

Pharmacotherapy of neuropsychiatric syndromes in neurologic disorders: definitional and regulatory aspects

artículo científico publicado en 2007

Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial

artículo científico publicado en 2013

Plasma methionine sulfoxide in persons with familial Alzheimer's disease mutations

artículo científico publicado en 2012

Plasma signaling proteins in persons at genetic risk for Alzheimer disease: influence of APOE genotype

artículo científico publicado en 2012

Positron emission tomography metabolic correlates of apathy in Alzheimer disease

artículo científico publicado en 2007

Practicality of a computerized system for cognitive assessment in the elderly

artículo científico publicado en 2008

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.

artículo científico publicado en 2016

Predicting cognitive decline in Alzheimer's disease: an integrated analysis

artículo científico publicado el 1 de noviembre de 2010

Prevalence and impact of medical comorbidity in Alzheimer's disease.

artículo científico publicado en 2002

Prognostic value of regional cerebral metabolism in patients undergoing dementia evaluation: comparison to a quantifying parameter of subsequent cognitive performance and to prognostic assessment without PET.

artículo científico publicado en 2003

Progressive cholinergic decline in Alzheimer's Disease: consideration for treatment with donepezil 23 mg in patients with moderate to severe symptomatology ⬇️

artículo científico publicado el 7 de febrero de 2011

Propositional density and apolipoprotein E genotype among persons at risk for familial Alzheimer's disease

artículo científico publicado en 2011

Proteomic changes in cerebrospinal fluid of presymptomatic and affected persons carrying familial Alzheimer disease mutations

artículo científico publicado en 2012

Provisional diagnostic criteria for depression in Parkinson's disease: report of an NINDS/NIMH Work Group

artículo científico publicado en 2006

Provisional diagnostic criteria for depression of Alzheimer disease

artículo científico publicado en 2002

Provisional diagnostic criteria for depression of Alzheimer's disease: description and review

artículo científico publicado en 2003

Psychiatric Aspects of Parkinson’s Disease, Parkinson’s Disease with Dementia, and Dementia with Lewy Bodies

artículo científico publicado en 2004

Quetiapine for agitation or psychosis in patients with dementia and parkinsonism

artículo científico publicado en 2007

Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease.

artículo científico publicado en 2018

Randomized controlled trials in frontotemporal dementia: cognitive and behavioral outcomes

artículo científico publicado en 2014

Randomized, controlled, proof-of-concept trial of MK-7622 in Alzheimer's disease.

artículo científico publicado en 2018

Randomized, double-blind, parallel-group, 48-week study for efficacy and safety of a higher-dose rivastigmine patch (15 vs. 10 cm²) in Alzheimer's disease

artículo científico publicado en 2012

Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting.

artículo científico publicado en 2017

Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer's disease

artículo científico publicado en 2004

Regression to the mean: implications for clinical trials of psychotropic agents in dementia

artículo científico publicado en 2004

Relational integration and executive function in Alzheimer's disease.

artículo científico publicado en 2004

Relative tolerability of Alzheimer's disease treatments

artículo científico publicado en 2008

Repurposed agents in the Alzheimer's disease drug development pipeline

artículo científico publicado en 2020

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

artículo científico publicado en 2007

Responder analysis of a randomized comparison of the 13.3 mg/24 h and 9.5 mg/24 h rivastigmine patch

artículo científico publicado en 2015

Reviewing the role of donepezil in the treatment of Alzheimer's disease

artículo científico

Revising the definition of Alzheimer's disease: a new lexicon.

artículo científico publicado en 2010

Revisiting Criteria for Psychosis in Alzheimer's Disease and Related Dementias: Toward Better Phenotypic Classification and Biomarker Research

scientific article published on 01 January 2020

Risk factors for behavioral abnormalities in mild cognitive impairment and mild Alzheimer's disease

artículo científico publicado en 2014

Rivastigmine in dementia associated with Parkinson's disease and Alzheimer's disease: similarities and differences

artículo científico publicado en 2007

Rivastigmine transdermal patch skin tolerability: results of a 1-year clinical trial in patients with mild-to-moderate Alzheimer's disease

artículo científico publicado en 2010

Role of Donepezil in the Management of Neuropsychiatric Symptoms in Alzheimer's Disease and Dementia with Lewy Bodies

artículo científico publicado en 2016

Searching for methods to detect, prevent, and treat Alzheimer's disease

artículo científico publicado en 2005

Sensitivity to change of composite and frequency scores of the Neuropsychiatric Inventory in mild to moderate dementia

artículo científico publicado en 2012

Sensitivity to change of composite and frequency scores of the neuropsychiatric inventory in mild cognitive impairment

artículo científico publicado en 2014

Serotonin 1A receptors in the living brain of Alzheimer's disease patients

artículo científico publicado en 2006

Sex Moderates the Impact of Diagnosis and Amyloid PET Positivity on Hippocampal Subfield Volume.

artículo científico publicado en 2018

Spanish instrument protocol: new treatment efficacy instruments for Spanish-speaking patients in Alzheimer disease clinical trials

artículo científico publicado en 2006

Speech and language in progressive nonfluent aphasia compared with early Alzheimer’s disease ⬇️

artículo científico publicado el 28 de octubre de 2003

Stakeholders' Perspectives on Preclinical Testing for Alzheimer's Disease

artículo científico publicado en 2015

Strategies for analysing behavioural data in clinical trials involving patients with Alzheimer's disease

artículo científico publicado en 1999

Structural correlates of apathy in Alzheimer's disease

artículo científico publicado en 2007

Subcortical hyperintensities in Alzheimer's disease: associated clinical and metabolic findings

artículo científico publicado en 2002

Subgroup analysis of US and non-US patients in a global study of high-dose donepezil (23 mg) in moderate and severe Alzheimer's disease.

artículo científico publicado en 2012

Subscale validation of the neuropsychiatric inventory questionnaire: comparison of Alzheimer's disease neuroimaging initiative and national Alzheimer's coordinating center cohorts

artículo científico publicado en 2013

Subtle Deficits in Instrumental Activities of Daily Living in Subtypes of Mild Cognitive Impairment ⬇️

artículo científico publicado el 26 de agosto de 2010

Surface feature-guided mapping of cerebral metabolic changes in cognitively normal and mildly impaired elderly

artículo científico publicado en 2009

Symptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease

artículo científico publicado en 2012

Taking stock: A multistakeholder perspective on improving the delivery of care and the development of treatments for Alzheimer's disease.

artículo científico publicado en 2014

The "Alzheimer's type" profile of semantic clustering in amnestic mild cognitive impairment

artículo científico publicado en 2014

The A431E mutation in PSEN1 causing familial Alzheimer's disease originating in Jalisco State, Mexico: an additional fifteen families

artículo científico publicado en 2006

The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery

artículo científico publicado en 2009

The Alzheimer's disease cooperative study prevention instrument project: longitudinal outcome of behavioral measures as predictors of cognitive decline

artículo científico publicado en 2014

The Cleveland Clinic Lou Ruvo Center for Brain Health: keeping memory alive

artículo científico publicado en 2014

The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations

artículo científico publicado en 2017

The Neuropsychiatric Inventory: Development and Applications

artículo científico publicado en 2020

The Sleep Disorders Inventory: an instrument for studies of sleep disturbance in persons with Alzheimer's disease

artículo científico publicado en 2003

The Truth behind the Zeros: A New Approach to Principal Component Analysis of the Neuropsychiatric Inventory

artículo científico publicado en 2020

The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers

artículo científico publicado en 2006

The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier)

artículo científico publicado en 2013

The impact of depressive symptoms on patients with Alzheimer disease

artículo científico publicado en 2003

The neuropsychiatric burden of neurological diseases in the elderly.

artículo científico publicado en 2005

The prevalence and correlates of neuropsychiatric symptoms in a population with Parkinson's disease in Mexico.

artículo científico publicado en 2002

The role of cholinergic agents in the management of behavioural disturbances in Alzheimer's disease

artículo científico publicado en 2000

The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration

artículo científico

The role of positron emission tomography in the diagnosis of Alzheimer's disease.

artículo científico publicado en 2004

The utility of the new research diagnostic criteria for Alzheimer's disease

artículo científico publicado en 2012

Three-dimensional gray matter atrophy mapping in mild cognitive impairment and mild Alzheimer disease

artículo científico publicado en 2007

Tolerability of ORM-12741 and effects on episodic memory in patients with Alzheimer's disease

artículo científico publicado en 2016

Top cited papers in International Psychogeriatrics: 6b. Behavioral disorders and caregivers' reaction in Taiwanese patients with Alzheimer's disease

artículo científico publicado en 2009

Treatment Combinations for Alzheimer's Disease: Current and Future Pharmacotherapy Options

scholarly article by Jeffrey L. Cummings et al published 2019 in Journal of Alzheimer's Disease

Treatment of Alzheimer's disease: current and future therapeutic approaches.

artículo científico publicado en 2004

Treatment of Alzheimer's disease: the role of symptomatic agents in an era of disease-modifying therapies

artículo científico publicado en 2007

Treatment of Depression in the Patient with Parkinson's Disease

artículo científico publicado en 1998

Treatment of neuropsychiatric disturbances in Parkinson's disease: future prospects and strategies

scholarly article

Treatments for behavioural disorders in neurodegenerative diseases: drug development strategies

artículo científico publicado en 2006

Use of atypical antipsychotics in the elderly

artículo científico publicado en 2008

Utility of the functional activities questionnaire for distinguishing mild cognitive impairment from very mild Alzheimer disease

artículo científico publicado en 2010

Validation of an Alzheimer's disease assessment battery in Asian participants with mild to moderate Alzheimer's disease

artículo científico publicado en 2014

Ventricular enlargement and its clinical correlates in the imaging cohort from the ADCS MCI donepezil/vitamin E study

artículo científico publicado en 2013

What can be inferred from the interruption of the semagacestat trial for treatment of Alzheimer's disease?

artículo científico publicado el 15 de noviembre de 2010

White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study

artículo científico publicado en 2003

Workshop reports from the third Asia-pacific regional meeting of the international working group on harmonization of dementia drug guidelines.

artículo científico publicado en 2006

[123I]N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)nortropane single-photon emission computed tomography brain imaging in the diagnosis of dementia with Lewy bodies

artículo científico

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda